{"id":"W4410267430","doi":"10.1016/j.bneo.2025.100115","title":"Tagraxofusp, a CD123-targeted therapy, for chronic myelomonocytic leukemia: final results of a phase 1/2 study","year":2025,"lang":"en","type":"article","venue":"Blood Neoplasia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Menarini Group","keywords":"Chronic myelomonocytic leukemia; Medicine; Interleukin-3 receptor; Leukemia; Oncology; Phase (matter); Internal medicine; Cancer research; Chemistry; Myelodysplastic syndromes; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002305781,0.001132588,0.001251529,0.0002610566,0.0002329816,0.0007814253,0.0005508814,0.001005301,0.001270182],"category_scores_gemma":[0.0007580709,0.000260963,0.0008934792,0.0002619889,0.000430962,0.0004582033,0.0001831724,0.001454807,0.0003932947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005530938,"about_ca_system_score_gemma":0.000818162,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008807988,"about_ca_topic_score_gemma":0.001543005,"domain_scores_codex":[0.9996302,0.0001896096,0.0000157509,0.00004258418,0.00004410749,0.00007778632],"domain_scores_gemma":[0.9995182,0.00009963146,0.00008285528,0.00004153063,0.00004908606,0.0002088153],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3192894,0.06699803,0.01719166,0.001964016,0.002848856,0.00121356,0.0008338243,0.007421971,0.1568885,0.0007592064,0.014846,0.409745],"study_design_scores_gemma":[0.2912775,0.6275681,0.04520046,0.0001549788,0.001523725,0.001322375,0.0001099458,0.003170492,0.01522802,0.0004792197,0.01389997,0.00006531109],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98576,0.008571262,0.001003013,0.0006317189,0.00009032298,0.001104909,0.001166817,0.00009936883,0.001572478],"genre_scores_gemma":[0.9816144,0.007032999,0.001974625,0.001319922,0.0001689267,0.001384597,0.00429509,0.00005453157,0.0021549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002305781,"threshold_uncertainty_score":0.01219428,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03274721435044482,"score_gpt":0.349430216785658,"score_spread":0.3166830024352132,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}